BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28806926)

  • 1. Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.
    Thöne K; Horn J; Mikolajczyk R
    BMC Infect Dis; 2017 Aug; 17(1):564. PubMed ID: 28806926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.
    Guerra FM; Rosella LC; Dunn S; Wilson SE; Chen C; Deeks SL
    Vaccine; 2016 Sep; 34(39):4678-4683. PubMed ID: 27527815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada.
    Steben M; Ouhoummane N; Rodier C; Sinyavskaya L; Brassard P
    J Med Virol; 2018 Mar; 90(3):592-598. PubMed ID: 28980715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health service utilisation for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine programme introduction: a retrospective longitudinal population-based study.
    Guerra FM; Rosella LC; Dunn S; Wilson SE; Chen C; Deeks SL
    BMJ Open; 2016 Mar; 6(3):e009914. PubMed ID: 26966057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.
    Shing JZ; Hull PC; Zhu Y; Gargano JW; Markowitz LE; Cleveland AA; Pemmaraju M; Park IU; Whitney E; Mitchel EF; Griffin MR
    Papillomavirus Res; 2019 Jun; 7():141-149. PubMed ID: 30980966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
    Osmani V; Fett S; Tauscher M; Donnachie E; Schneider A; Klug SJ
    BMC Cancer; 2022 Dec; 22(1):1293. PubMed ID: 36494790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients.
    Woestenberg PJ; Guevara Morel AE; Bogaards JA; Hooiveld M; Schurink-van 't Klooster TM; Hoebe CJPA; van der Sande MAB; van Benthem BHB
    Clin Infect Dis; 2021 Jul; 73(2):291-297. PubMed ID: 32421775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women--an ecological study.
    Sandø N; Kofoed K; Zachariae C; Fouchard J
    Acta Derm Venereol; 2014 May; 94(3):288-92. PubMed ID: 24150529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007-2018).
    Cocchio S; Prandi GM; Furlan P; Bertoncello C; Fonzo M; Saia M; Baldovin T; Baldo V
    BMC Infect Dis; 2020 Nov; 20(1):857. PubMed ID: 33208109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.
    Drolet M; Bénard É; Boily MC; Ali H; Baandrup L; Bauer H; Beddows S; Brisson J; Brotherton JM; Cummings T; Donovan B; Fairley CK; Flagg EW; Johnson AM; Kahn JA; Kavanagh K; Kjaer SK; Kliewer EV; Lemieux-Mellouki P; Markowitz L; Mboup A; Mesher D; Niccolai L; Oliphant J; Pollock KG; Soldan K; Sonnenberg P; Tabrizi SN; Tanton C; Brisson M
    Lancet Infect Dis; 2015 May; 15(5):565-80. PubMed ID: 25744474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals.
    Nygård S; Nygård M; Orumaa M; Hansen BT
    Vaccine; 2023 Aug; 41(37):5469-5476. PubMed ID: 37516572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal Trends in the Incidence of Anogenital Warts: Impact of Human Papillomavirus Vaccination.
    Naleway AL; Crane B; Smith N; Francisco M; Weinmann S; Markowitz LE
    Sex Transm Dis; 2020 Mar; 47(3):179-186. PubMed ID: 31880738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
    Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
    Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
    Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
    BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.
    Brotons M; Monfil L; Roura E; Duarte-Salles T; Casabona J; Urbiztondo L; Cabezas C; Bosch FX; de Sanjosé S; Bruni L
    Prev Med; 2020 Sep; 138():106166. PubMed ID: 32565118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination.
    Tyros G; Mastraftsi S; Gregoriou S; Nicolaidou E
    Int J STD AIDS; 2021 Jan; 32(1):4-13. PubMed ID: 33167803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Declines in Anogenital Warts Among Age Groups Most Likely to Be Impacted by Human Papillomavirus Vaccination, United States, 2006-2014.
    Flagg EW; Torrone EA
    Am J Public Health; 2018 Jan; 108(1):112-119. PubMed ID: 29161070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
    Dominiak-Felden G; Gobbo C; Simondon F
    PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017.
    Checchi M; Mesher D; Mohammed H; Soldan K
    Sex Transm Infect; 2019 Aug; 95(5):368-373. PubMed ID: 30723186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.